• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


4.5500 EUR 0.0600 1.34%

As of 11:35:00 ET on 04/24/2014.

Snapshot for MDxHealth (MDXH)

Open: 4.4900 Day's Range: 4.4500 - 4.5900 Volume: 120,166
Previous Close: 4.4900 52wk Range: 1.9200 - 5.2900 1-Yr Rtn: +112.62%

Stock Chart for MDXH

No chart data available.
  • MDXH:BB 4.5500
  • 1D
  • 1M
  • 1Y
Interactive MDXH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MDXH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) -0.3543
Est. EPS (EUR) (12/2014) -0.1400
Est. PEG Ratio -
Market Cap (M EUR) 155.50
Shares Outstanding (M) 34.25
30 Day Average Volume 214,114
Price/Book (mrq) -
Price/Sale (ttm) 24.5985
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MDXH

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MDXH

MDxHealth is a molecular diagnostics company that develops and commercializes oncology based molecular diagnostic testing for personalized medicine. The Company's tests are based on proprietary gene methylation technology and assist physicians and their patients with the accurate diagnosis of cancer, prognosis of recurrence risk and prediction of response to a specific therapy.

Jan GroenChief Executive OfficerFrancis OtaExec VP:Finance
Christopher ThibodeauExec VP:Commercial OpsJoseph SolleeExec VP:Corporate Dev & Legal
More Company Profile & Key Executives for MDXH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil